The present study aimed to analyze the expression profile of the microRNAs previously described as associated with childhood ALL, miR-92a, miR-100, miR-125a-5p, miR-128a, miR-181b, miR-196b and let-7e, and their association with biological/prognostic features in 128 consecutive samples of childhood acute lymphoblastic leukemia (ALL) by quantitative real-time PCR. A significant association was observed between higher expression levels of miR-196b and T-ALL, miR-100 and patients with low white blood cell count at diagnosis and t(12;21) positive ALL. These findings suggest a potential activity of these microRNAs in pediatric ALL biology. (C) 2011 Elsevier Ltd. All rights reserved.Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fun...
MicroRNAs (miRNAs) expression profiles were screened in plasma samples from pediatric patients with ...
Acute lymphoblastic leukemia (ALL) is an heterogeneous disease comprising several subentities that d...
Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and i...
The present study aimed to analyze the expression profile of the microRNAs previously described as a...
AbstractThe present study aimed to analyze the expression profile of the microRNAs previously descri...
Dysregulation of microRNA (miRNA) expression contributes to the pathogenesis of several clinical con...
Copyright © 2014 Muhterem Duyu et al. This is an open access article distributed under the Creative ...
Acute lymphoblastic leukemia (ALL) is the most common type of pediatric neoplasia. Highly heterogene...
textabstractBackground MicroRNA regulate the activity of protein-coding genes including those involv...
In spite of the improved efficacy of therapy, it still fails in 15-20 % of childhood acute lymphobla...
BACKGROUND: Recent reports have indicated that microRNAs (miRNAs) play a critical role in malignanci...
MicroRNAs (miRNAs) regulate the expression of protein-coding genes and represent potential biomarker...
MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate the expression of target genes...
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, whereas acute myeloid leukem...
Despite the clinical success of acute lymphoblastic leukemia (ALL) therapy, toxicity is frequent. Th...
MicroRNAs (miRNAs) expression profiles were screened in plasma samples from pediatric patients with ...
Acute lymphoblastic leukemia (ALL) is an heterogeneous disease comprising several subentities that d...
Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and i...
The present study aimed to analyze the expression profile of the microRNAs previously described as a...
AbstractThe present study aimed to analyze the expression profile of the microRNAs previously descri...
Dysregulation of microRNA (miRNA) expression contributes to the pathogenesis of several clinical con...
Copyright © 2014 Muhterem Duyu et al. This is an open access article distributed under the Creative ...
Acute lymphoblastic leukemia (ALL) is the most common type of pediatric neoplasia. Highly heterogene...
textabstractBackground MicroRNA regulate the activity of protein-coding genes including those involv...
In spite of the improved efficacy of therapy, it still fails in 15-20 % of childhood acute lymphobla...
BACKGROUND: Recent reports have indicated that microRNAs (miRNAs) play a critical role in malignanci...
MicroRNAs (miRNAs) regulate the expression of protein-coding genes and represent potential biomarker...
MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate the expression of target genes...
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, whereas acute myeloid leukem...
Despite the clinical success of acute lymphoblastic leukemia (ALL) therapy, toxicity is frequent. Th...
MicroRNAs (miRNAs) expression profiles were screened in plasma samples from pediatric patients with ...
Acute lymphoblastic leukemia (ALL) is an heterogeneous disease comprising several subentities that d...
Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and i...